New Study Links Roundup Exposure to Major Fertility Problems

Exposure to glyphosate, the active ingredient in Roundup weed killer, is at the center of growing concerns about female reproductive health, following a recent study published in Reproductive Sciences. The research reveals alarming connections between glyphosate-based herbicides like Roundup and female fertility problems, potentially linking the chemical to increased oxidative stress, hormonal disruption, and cellular damage in both ovarian and uterine tissues. 

Alleged Health Effects of Exposure to Glyphosate-Based Weed Killers

With approximately 240 million pounds of glyphosate sprayed annually on U.S. farms, the potential public health implications of alleged Roundup health risks are substantial. In addition to growing concerns about the potential link between Roundup and non-Hodgkin’s lymphoma, a new study from Wayne State University School of Medicine reveals that exposure to glyphosate-based herbicides like Roundup may also damage female reproductive health through multiple biological mechanisms. 

Published in March 2025 in the journal Reproductive Sciences, this comprehensive review highlights a potential link between Roundup weed killer exposure and conditions like polycystic ovary syndrome (PCOS) and endometriosis, both leading causes of infertility. These findings add to the mounting evidence that allegedly connects Roundup products to serious health concerns, while raising questions about the Environmental Protection Agency’s (EPA) position that glyphosate remains safe for human use.

How Can Roundup Exposure Lead to Fertility Problems? 

The research indicates that glyphosate adversely affects women’s reproductive systems through four primary mechanisms: 

• Increasing oxidative stress,
• Altering the production and regulation of reproductive hormones, 
• Reducing ovarian function, and 
• Causing pathological changes in the ovaries and uterus. 

These effects potentially elevate the risk of infertility and reproductive disorders such as endometriosis and PCOS.

Additionally, the study found that glyphosate exposure can damage ovarian follicles essential for hormone production and egg development, making conception more difficult. It may also disrupt embryo implantation by impairing blood flow to the uterus, potentially increasing the risk of pregnancy complications.

Glyphosate: The World’s Most Ubiquitous Weed Killer

These new study findings are particularly concerning given the widespread use of glyphosate-based herbicides. Since Roundup’s commercial introduction in 1974, more than 3.5 billion pounds of glyphosate have been applied in the United States alone. The EPA maintains that glyphosate is safe for humans; however, this position is increasingly challenged by emerging research.

Previous animal studies have demonstrated fertility issues with glyphosate at doses in line with current regulatory limits. Research published in June 2024 detected glyphosate in human seminal plasma at concentrations four times higher than those observed in blood plasma, suggesting potential reproductive hazards for both sexes.

This new research adds significant weight to ongoing Roundup lawsuit concerns by establishing clearer connections between the allegedly harmful herbicide and specific female reproductive health conditions. The researchers emphasize that increased research efforts are urgently needed regarding glyphosate’s safety as it pertains to female reproduction.

Roundup Lawsuits Highlight Ongoing Health and Legal Concerns

Bayer faces an unprecedented wave of litigation over Roundup weed killer, with thousands of lawsuits filed against the company and its Monsanto subsidiary to date. Plaintiffs involved in the Roundup litigation allege that exposure to the herbicide caused their non-Hodgkin’s lymphoma and other related cancers. In June 2020, Bayer announced a settlement of nearly $11 billion to resolve around three-quarters of the approximately 125,000 filed and unfiled Roundup claims. Nevertheless, thousands of active Roundup lawsuits remain pending as of May 2025. 

Bayer Attempts to Avoid Liability for Roundup Cancer Claims

Bayer has persistently attempted to shield itself from liability for cancer claims related to Roundup, recently lobbying Congress for legal immunity and arguing that federal EPA approval should block state-level lawsuits. The company has even warned lawmakers it may withdraw Roundup from the U.S. market if litigation costs continue escalating. The legal battle shows no signs of resolution, as newly diagnosed patients continue to emerge.

What This Means for Public Health and Future Research

The conflict between scientific assessments underscores the complexity surrounding glyphosate safety. Even as the EPA maintains that “glyphosate is not likely to be carcinogenic to humans,” the International Agency for Research on Cancer has classified glyphosate as a “probable human carcinogen.” This scientific disagreement creates significant challenges for public health policy. Future Roundup research must address current gaps in understanding, particularly regarding long-term reproductive health effects. Until more conclusive evidence emerges, the precautionary principle suggests minimizing exposure to Roundup, especially for vulnerable populations.